Large-cap biotech stocks will just tread water as sector sizzles

Large-cap biotech stocks will just tread water as sector sizzles


That's the advice from analysts covering the sector as shares of companies such as Celgene Corp. and Regeneron Pharmaceuticals Inc. have failed to keep pace with their smaller rivals over the past six months. Even as the Nasdaq Biotech Index rose for a seventh straight day on Monday, its longest streak since March, analysts don't expect the largest names in the group will see a sustained rebound in the second half of the year.



from Biotech News